Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Biocartis Group NV (BCART)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.29 0.00    0.00%
31/12 - Closed. Currency in EUR ( Disclaimer )
Type:  Equity
Market:  Belgium
ISIN:  BE0974281132 
  • Volume: 0
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 0.29 - 0.29
Biocartis Group NV 0.29 0.00 0.00%

BCART Recent Sentiments

 
This page contains information on users’ sentiments for the Biocartis Group NV stock, which are displayed both on charts of different periods of time and on a detailed table.
BearishBullish
Start Date Username Call Open Rate End Date Chg. %
Apr 08, 2024 Marc Vertongen   0.29 0.00%
Dec 21, 2023 Bjorn Bjorn   0.29 Dec 25, 2023 @ 0.29 0.00%
Oct 16, 2023 kristof langbeen   0.29 Nov 30, 2023 @ 0.29 0.00%
Sep 26, 2023 Marc Vertongen   0.29 Nov 20, 2023 @ 0.29 0.00%
Sep 26, 2023 Bart Schepers   0.29 Nov 30, 2023 @ 0.29 0.00%
Sep 25, 2023 Michiel Voeten   0.29 Nov 30, 2023 @ 0.29 0.00%
Aug 24, 2023 Marc Vertongen   0.33 Sep 19, 2023 @ 0.29 +12.12%
Jul 05, 2023 Burak Alp   0.38 Nov 30, 2023 @ 0.29 +23.68%
Jul 05, 2023 Roel Segers   0.38 Nov 30, 2023 @ 0.29 -23.68%
Jul 05, 2023 Jos Deprutser   0.39 Nov 30, 2023 @ 0.29 +25.64%
Jul 04, 2023 Guy Van Rompuy   0.37 Nov 30, 2023 @ 0.29 -21.62%
Jun 21, 2023 Marc Vertongen   0.37 Aug 17, 2023 @ 0.35 +5.41%
Jun 20, 2023 Wim Veenhof   0.38 Nov 30, 2023 @ 0.29 -23.68%
Jun 19, 2023 LUC BEERTEN   0.39 Jul 07, 2023 @ 0.36 +7.69%
Jun 16, 2023 Uve Peet   0.42 Nov 30, 2023 @ 0.29 -30.95%
Jun 16, 2023 Ma VERT   0.42 Sep 26, 2023 @ 0.29 +30.95%
May 29, 2023 Baudouin Nisole   0.56 Aug 02, 2023 @ 0.34 -39.29%
May 25, 2023 alex lelievre   0.57 Nov 30, 2023 @ 0.29 +49.12%
May 10, 2023 Julio Alonso Iglesias   0.60 Nov 30, 2023 @ 0.29 -51.67%
Apr 21, 2023 Nikodemus II   0.64 Nov 30, 2023 @ 0.29 -54.69%
Apr 20, 2023 LUC BEERTEN   0.62 May 11, 2023 @ 0.60 +3.23%
Apr 17, 2023 Pierre hiard   0.71 Nov 30, 2023 @ 0.29 -59.15%
Apr 13, 2023 Bruno Vanden Broeck   0.72 May 09, 2023 @ 0.58 -19.44%
Apr 06, 2023 Roel Segers   0.62 May 09, 2023 @ 0.58 -6.45%
Apr 04, 2023 Julio Alonso Iglesias   0.61 May 09, 2023 @ 0.58 -4.92%
Apr 03, 2023 henri procureur   0.60 Apr 10, 2023 @ 0.63 +5.00%
Mar 31, 2023 Danny De Winter   0.61 Apr 21, 2023 @ 0.63 +3.28%
Mar 15, 2023 Henri Procureur   0.63 Mar 20, 2023 @ 0.63 0.00%
Mar 03, 2023 Kris Rens   0.67 Mar 24, 2023 @ 0.63 +5.97%
Mar 02, 2023 Bjorn Bjorn   0.67 Mar 06, 2023 @ 0.67 0.00%
Mar 02, 2023 Julio Alonso Iglesias   0.67 Mar 24, 2023 @ 0.63 -5.97%
Feb 23, 2023 Bjorn Bjorn   0.64 Feb 27, 2023 @ 0.65 +1.56%
Feb 23, 2023 Marc Vertongen   0.64 Mar 17, 2023 @ 0.64 0.00%
Feb 20, 2023 Bertrand van Renynghe   0.64 Mar 17, 2023 @ 0.64 0.00%
Feb 17, 2023 Thomas L   0.63 Mar 10, 2023 @ 0.65 +3.17%
Feb 09, 2023 Danny De Winter   0.68 Mar 03, 2023 @ 0.68 0.00%
Feb 08, 2023 Pierre hiard   0.72 Mar 03, 2023 @ 0.68 -5.56%
Feb 08, 2023 Sebastian Olewicz   0.72 Mar 03, 2023 @ 0.68 -5.56%
Jan 30, 2023 Julio Alonso Iglesias   0.72 Feb 24, 2023 @ 0.65 -9.72%
Jan 24, 2023 RUBEN calvo ingelmo   0.71 Jan 29, 2023 @ 0.70 +1.41%
Jan 19, 2023 Thierry De Block   0.72 Feb 10, 2023 @ 0.64 -11.11%
Jan 19, 2023 Robin Belien   0.74 Feb 10, 2023 @ 0.64 -13.51%
Jan 18, 2023 Luc Arnould   0.76 Jan 23, 2023 @ 0.72 +5.26%
Jan 16, 2023 Marc Vertongen   0.62 Jan 24, 2023 @ 0.71 -14.52%
Jan 04, 2023 Julio Alonso Iglesias   0.60 Jan 27, 2023 @ 0.70 +16.67%
Jan 03, 2023 Daniel Lav   0.56 Jan 09, 2023 @ 0.57 -1.79%
Dec 30, 2022 Thomas L   0.53 Jan 20, 2023 @ 0.71 -33.96%
Dec 23, 2022 Marc Vertongen   0.53 Jan 13, 2023 @ 0.59 +11.32%
Dec 20, 2022 Joe Uyttersprot   0.53 Jan 13, 2023 @ 0.59 +11.32%
Dec 20, 2022 Daniel Lav   0.53 Dec 26, 2022 @ 0.53 0.00%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

BCART Comments

Write your thoughts about Biocartis Group NV
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Roel Munt
CrustyCrabz Nov 13, 2020 11:47AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
seems a risky one
Kim Maes
Kim Maes Nov 11, 2020 3:12AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Goeiemorgen, als je wil kopen onder de 5 is het nu de moment....
Kim Maes
Kim Maes Nov 10, 2020 6:39AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Big stock
Dimitri Tasevski
Dimitri Tasevski Sep 19, 2020 5:46AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
This stock will go 200% high next week
Mark Swaelen
Mark Swaelen Sep 29, 2019 5:34PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
In what sense does Biocartis differ from Theranos of Elisabeth Holmes which was one big lie ?
Robbe Cobb
Cobb Sep 29, 2019 5:34PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Theranos never delivered peer reviewed research and wasn't transparent.. . . Biocartis has a lot of information available on their website.. . . I'm sure the Theranos scandal has hurt Biocartis' sales in the short term but I don't see how it will have an effect in the long term.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email